HSS Journal

, Volume 8, Issue 1, pp 35–36 | Cite as

Osteoarthritis: The Rheumatologist’s Perspective

HSS OSTEOARTHRITIS SYMPOSIUM: FRONTIERS IN OA
First Online:
Received:
Accepted:

Keywords

osteoarthritis mortality pain treatment 
This is a preview of subscription content, log in to check access.

Notes

Disclosure

Dr. Hochberg serves as a consultant to Abbott Laboratories, Astra- Zeneca Pharmaceutical, Eli Lilly, EMD Serono, Merck & Co., NiCox, Pfizer, Pozen, and Theralogix and is a member of the Medical Advisory Board and has stock ownership in Theralogix.

References

  1. 1.
    Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008;58:26–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Lane NE, Brandt K, Hawker G, et al. OARSI–FDA Initiative: Defining the disease state of osteoarthritis. Osteoarthritis Cart 2011;19:478–82.CrossRefGoogle Scholar
  3. 3.
    Hochberg MC. Mortality in osteoarthritis. Clin Exp Rheumatol 2008;26:S120–4.PubMedGoogle Scholar
  4. 4.
    Losina E, Walensky RP, Reichmann WM, et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med 2011;154:217–26.PubMedGoogle Scholar
  5. 5.
    Nuesch E, Dieppe P, Reichenbach S, et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: Population based cohort study. BMJ 2011;342:d1165.PubMedCrossRefGoogle Scholar
  6. 6.
    American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;46:1905–15.Google Scholar
  7. 7.
    Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Osteoarthritis Cart 2008;16:137–62CrossRefGoogle Scholar
  8. 8.
    Tallis F. Vienna Secrets. Arrow Books, U.K., 2009Google Scholar
  9. 9.
    Skinner J, Weinstein JN, Sporer SM, Wennberg ME. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med 2003;349:1350PubMedCrossRefGoogle Scholar
  10. 10.
    Gossec L, Paternotte S, Mailefert JF, et al. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: An international cross-sectional study of 1909 patients. Report of the OARSI–OMERACT task force on total joint replacement. Osteoarthritis Cart 2011;19:147–54CrossRefGoogle Scholar
  11. 11.
    Shurupoff K, Park DH, Hochberg MC. The use of classification trees to determine criteria for “virtual total joint replacement” for patients with hip and knee osteoarthritis. Osteoarthritis Cart 2011;19:in pressGoogle Scholar

Copyright information

© Hospital for Special Surgery 2011

Authors and Affiliations

  1. 1.University of Maryland School of MedicineBaltimoreUSA

Personalised recommendations